Cargando…

2-[18F]FDG-PET/CT in Cancer of Unknown Primary Tumor—A Retrospective Register-Based Cohort Study

We investigated the impact of 2-[18F]FDG-PET/CT on detection rate (DR) of the primary tumor and survival in patients with suspected cancer of unknown primary tumor (CUP), comparing it to the conventional diagnostic imaging method, CT. Patients who received a tentative CUP diagnosis at Odense Univers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rimer, Heidi, Jensen, Melina Sofie, Dahlsgaard-Wallenius, Sara Elisabeth, Eckhoff, Lise, Thye-Rønn, Peter, Kristiansen, Charlotte, Hildebrandt, Malene Grubbe, Gerke, Oke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532746/ https://www.ncbi.nlm.nih.gov/pubmed/37754942 http://dx.doi.org/10.3390/jimaging9090178

Ejemplares similares

The Pattern of Metastatic Breast Cancer: A Prospective Head-to-Head Comparison of [(18)F]FDG-PET/CT and CE-CT
por: Gram-Nielsen, Rosa, et al.
Publicado: (2023)

Comparison of Image Quality and Quantification Parameters between Q.Clear and OSEM Reconstruction Methods on FDG-PET/CT Images in Patients with Metastatic Breast Cancer
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2023)

2-[(18)F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer
por: Vogsen, Marianne, et al.
Publicado: (2023)

Benefits and harms of implementing [(18)F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study
por: Vogsen, Marianne, et al.
Publicado: (2021)

Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer
por: Holm, Jorun, et al.
Publicado: (2020)

Cost-effectiveness of 2-[(18)F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2023)

FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review
por: Helland, Fredrik, et al.
Publicado: (2019)

Prevalence of focal incidental breast uptake on FDG-PET/CT and risk of malignancy: a systematic review and meta-analysis
por: Aarstad, Else Marie, et al.
Publicado: (2019)

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST
por: Vogsen, Marianne, et al.
Publicado: (2021)

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond
por: Hildebrandt, Malene Grubbe, et al.
Publicado: (2019)

Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy
por: Hansen, Jeanette Ansholm, et al.
Publicado: (2021)

Prognostic Value of Dual-Time-Point (18)F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2020)

Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2021)

Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer
por: Baun, Christina, et al.
Publicado: (2018)

Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
por: Gerke, Oke, et al.
Publicado: (2017)

The Utility of 18F‐FDG PET/CT in Patients With Clinical Suspicion of Polymyalgia Rheumatica and Giant Cell Arteritis: A Prospective, Observational, and Cross‐sectional Study
por: Emamifar, Amir, et al.
Publicado: (2020)

Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer
por: Sørensen, Jonas S., et al.
Publicado: (2020)

(18)F-FDG PET/CT for detection of the primary tumor in adults with extracervical metastases from cancer of unknown primary: A systematic review and meta-analysis
por: Burglin, Synne Alexandra, et al.
Publicado: (2017)

Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity
por: Dyrvig, Anne-Kirstine, et al.
Publicado: (2017)

Prevalence of Newly Diagnosed Malignancies in Patients with Polymyalgia Rheumatica and Giant Cell Arteritis, Comparison of 18F-FDG PET/CT Scan with Chest X-ray and Abdominal Ultrasound: Data from a 40 Week Prospective, Exploratory, Single Centre Study
por: Emamifar, Amir, et al.
Publicado: (2020)

Learning from patient involvement in a clinical study analyzing PET/CT in women with advanced breast cancer
por: Vogsen, Marianne, et al.
Publicado: (2020)

FDG PET/CT in carcinoma of unknown primary
por: Kwee, Thomas C., et al.
Publicado: (2009)

Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
por: Park, Jong Sun, et al.
Publicado: (2011)

Role of FDG-PET/CT in children with fever of unknown origin
por: Pijl, Jordy P., et al.
Publicado: (2020)

Diagnostic value of FDG-PET/CT in fever of unknown origin
por: Elshalakani, Maha Omar Mohamed, et al.
Publicado: (2022)

Clinical presentation and treatment response in patients with polymyalgia rheumatica and giant cell arteritis during a 40-week follow-up
por: Emamifar, Amir, et al.
Publicado: (2021)

The Diagnostic Role of FDG PET/CT in Patients with Fever of Unknown Origin
por: Ergül, Nurhan, et al.
Publicado: (2011)

Potential Usefulness of FDG PET/CT in Patients with Sepsis of Unknown Origin
por: Tseng, Jing-Ren, et al.
Publicado: (2013)

FDG-PET or PET/CT in Fever of Unknown Origin: The Diagnostic Role of Underlying Primary Disease
por: Ergül, Nurhan, et al.
Publicado: (2011)

A prospective study on dual time (18)F-FDG-PET/CT in high-risk prostate cancer patients
por: Mortensen, Mike Allan, et al.
Publicado: (2018)

Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis
por: Emamifar, Amir, et al.
Publicado: (2021)

A randomised trial of [(18)F]PSMA‐1007‐PET/CT versus NaF‐PET/CT for staging primary prostate cancer: A trial protocol
por: Buch‐Olsen, Karen Middelbo, et al.
Publicado: (2023)

Localization of acute pyelonephritis in pyrexia of unknown origin using FDG PET/CT
por: Solav, Shrikant, et al.
Publicado: (2020)

Diagnostic Value of (18)F-FDG PET/CT in Patients with Carcinoma of Unknown Primary
por: Cengiz, Arzu, et al.
Publicado: (2018)

Evaluation of radiation treatment volumes for unknown primaries of the head and neck in the era of FDG PET
por: Platek, Alexis, et al.
Publicado: (2020)

Role of FDG-PET/CT in Assessing the Correlation Between Blood Pressure and Myocardial Metabolic Uptake
por: Rojulpote, Chaitanya, et al.
Publicado: (2020)

Semantic Dementia Diagnosed by F-18 FDG PET/MRI: Co-registered Images
por: Jolepalem, Prashant, et al.
Publicado: (2013)

Diagnostic value of 18F-FDG-PET and PET-CT in children with fever of unknown origin or unexplained signs of inflammation
por: Däbritz, J, et al.
Publicado: (2008)

Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis
por: Kwee, Thomas C., et al.
Publicado: (2008)

Diagnosis of Brachiocephalic Thrombophlebitis as the Cause of Fever of Unknown Origin by 18F-FDG-PET/CT
por: Demirev, Anastas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_btbq8hflh68043iouf3ute73aj